|
|
Article: LFB Provides $10 Million of Funding To GTC Biotherapeutics.
- Article from:
- Biotech Week
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GTC Biotherapeutics, Inc. ("GTC", NASDAQ: GTCB) announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire francais du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC. In addition, LFB has converted the convertible preferred stock it previously purchased under these agreements in July into a total of 10.6 million shares of common stock to ...
Related newspaper, magazine, and journal articles:
|
|
Article: GTC Biotherapeutics Receives NASDAQ Notice; Intends ...
Biotech Week;
September 30, 2009 ;
700+ words
...GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ ... Company on June 19, 2009 (see also GTC Biotherapeutics, Inc.). GTC intends to request ... request for continued listing. About GTC Biotherapeutics, Inc. GTC Biotherapeutics develops ...
|
|